Your browser doesn't support javascript.
loading
Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.
Jörg, L; Pecaric-Petkovic, T; Reichenbach, S; Coslovsky, M; Stalder, O; Pichler, W; Hausmann, O.
Afiliação
  • Jörg L; Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Pecaric-Petkovic T; Adverse Drug Reactions, Analysis and Consulting, ADR-AC GmbH, Bern, Switzerland.
  • Reichenbach S; Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Coslovsky M; Clinical Trial Unit, University of Bern, Bern, Switzerland.
  • Stalder O; Clinical Trial Unit, University of Bern, Bern, Switzerland.
  • Pichler W; Clinical Trial Unit, University of Bern, Bern, Switzerland.
  • Hausmann O; Adverse Drug Reactions, Analysis and Consulting, ADR-AC GmbH, Bern, Switzerland.
Clin Exp Allergy ; 48(2): 196-204, 2018 02.
Article em En | MEDLINE | ID: mdl-29164723
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Urticária / Basófilos / Antialérgicos / Omalizumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Urticária / Basófilos / Antialérgicos / Omalizumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article